Developer docs
API playgroundTry for free, no card

Search company profiles

LABMaiTE

Full company profile

uuid000a8kt

Namestring
LABMaiTE
Legal namestring
Labmaite GmbH
Websiteurl
labmaite.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

LABMaiTE GmbH is a privately held German AI company founded in 2021 and headquartered in Freiburg (Türkheimerstraße 4a, HRB 725466) that builds AI and automation software for two adjacent life-science verticals: cancer research and bioprocess technology. The company was spun out of a collaboration between BioThera Roland Mertelsmann Foundation, the University of Freiburg, and the University Hospital Freiburg, and operates with a 1-10 person team of biologists, bioprocess engineers and machine learning researchers.

The company's product surface is organized around two integrated technology stacks. The first is a computer-vision-based image analysis platform that extracts cell count, viability, confluency, tracking, and membrane roughness features from label-free microscopic images and is positioned for cancer research and neurodegenerative-disease drug screening. The second is the AMLAMaiTE bioprocess optimization system, which combines advanced probabilistic models with a fully automated microbioreactor to determine optimal culture conditions and has been shown to increase biomass output by up to 30% versus traditional Design of Experiments approaches. Both stacks are protected by granted patents and are being extended into CAR T-cell production optimization through the BMBF-funded iCARus project with Hochschule Kempten.

LABMaiTE monetizes through custom AI solutions and managed bioprocess services sold via a sales-led, enterprise-targeted go-to-market motion that relies on direct engagement, 'Request a Demo' CTAs, and presence at major industry events such as ACHEMA 2024, MEDICA 2023, and the BioProScale Symposium 2024. To date, the only disclosed funding is approximately EUR 480,000 in non-dilutive BMBF grant money spread over three years for the iCARus project; no equity financing rounds, named end customers, or revenue figures have been disclosed.

Short descriptiontext

LABMaiTE GmbH is a Freiburg-based AI company that builds computer-vision image analysis for cancer research and probabilistic-model bioprocess optimization (AMLAMaiTE) for biomanufacturing and precision fermentation clients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersFreiburg Im Breisgau, Germany
HQ citystring
Freiburg Im Breisgau
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI image analysis, bioprocess optimization, cell characterization software, media optimization, custom research automation
Industry3 codes
PRIMARYHLAGAJAG
Lab Automation, Instrument Control & Workflow Orchestration Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAMAK
Lab Analytics, Utilization Management & Operational Intelligence
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAAAIAE
AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Biotechnology AI Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Custom AI Solutions and Services
TypeProfessional Services
Description

LABMaiTE offers customized data analysis, data insights and smart experimental design services. They process client experimental data to deliver optimized conditions for maximum production, operating as a seamless extension of the client's existing process.

labmaite.com
2AMLAMaiTE Bioprocess System
TypeManaged Services
Description

Tailored bioprocess solutions using their proprietary AMLAMaiTE system for media optimization in biomanufacturing and precision fermentation applications.

labmaite.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1AMLAMaiTE
Description

AI-powered bioprocess media optimization system using advanced Probabilistic Models to rapidly determine optimal culture conditions, outperforming traditional Design of Experiments (DoE) methods. The system achieves up to 30% increase in biomass output compared to industry standards.

labmaite.com
Core offering1 text field

LABMaiTE develops AI-powered software and automation solutions for cancer research and bioprocess technology. Its products include the AMLAMaiTE system for media optimization using probabilistic models (demonstrating up to 30% biomass increase over DoE methods) and computer-vision-based AI image analysis for cell characterization. The company also delivers tailored automation and custom AI analytics services as a seamless extension of client laboratory workflows.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Up to 30% increase in biomass output compared to industry standards (DoE) in bacteria growth optimization with 8 media components
+2 more records
Product overview1 text field

LABMaiTE offers a unified AI and automation solutions platform comprising two main product areas: (1) AI Image Analysis and Cell Characterization modules for cancer research, providing computer vision-based analysis of microscopic images with cell count, viability, confluency, and tracking capabilities, and (2) the AMLAMaiTE system for bioprocess media optimization using advanced Probabilistic Models that outperform traditional DoE methods. The company also provides customized automation solutions as add-on modules. All products share core AI/ML technology for processing optical data and images, with the AMLAMaiTE system leveraging the same ML foundation for growth optimization. LABMaiTE's patented technology is fully-automated and AI-based, designed to save time and money across the research process.

Product and service4 records
1AI Image Analysis
CategoryComputer Vision Software for Life Sciences
Description

Computer vision software that analyzes microscopic images to extract hidden insights beyond basic features for cancer research and biology laboratories. Capabilities include cell count, cell viability, cell confluency, cell tracking, membrane roughness, and custom analyses; the AI model distinguishes active and inactive cells, matching human researchers and detecting cells that traditional methods miss. Designed for research institutions working on drug screening and neurodegenerative disease research.

2AMLAMaiTE Bioprocess Optimization System
CategoryBioprocess Optimization Software
Description

State-of-the-art bioprocess media optimization system using advanced Probabilistic Models to rapidly determine optimal culture conditions. Outperforms traditional Design of Experiments (DoE) methods and achieves up to 30% increase in biomass output while reducing time and cost. Includes fully automated microbioreactor capabilities with real-time monitoring for biomanufacturing and precision fermentation customers.

3Cell Characterization
CategoryComputer Vision Software for Life Sciences
Description

AI-powered cell analysis technology that accurately distinguishes active and inactive cells, matching human researchers and detecting cells that traditional methods miss. Designed to enhance drug screening for neurodegenerative diseases including Alzheimer's, multiple sclerosis, and Parkinson's for cancer research and biology laboratories.

4Customized AI Data Analysis and Smart Experimental Design Services
CategoryBioprocess Consulting and Analytics Services
Description

Professional services offering in which LABMaiTE processes client experimental data, delivers data insights and designs smart experiments to optimize culture conditions for maximum production. Operates as a managed/extension service for biomanufacturing clients using the AMLAMaiTE platform and underlying probabilistic models.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-03-01
Description

LABMaiTE teams up with Prof. Frieder Heieck for BMBF-funded iCARus project focused on CAR T-cell production optimization. Project funded through KMU-Innovativ program with approximately €480,000 over 3 years.

2Hochschule München (University of Applied Sciences)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-12-01
Description

Collaborated on the AMLAMO project which wrapped up at end of 2023. Dr. Ing. Frédéric Lapierre showcased breakthrough results at BioProScale Symposium 2024. Prof. Dr. Robert Huber from Hochschule München serves on the advisory board.

labmaite.com
3BioThera Roland Mertelsmann Foundation
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Founding partner of LABMaiTE alongside University of Freiburg and University Hospital Freiburg. Ensures commitment to excellence and guides the company to real problems to solve.

labmaite.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Founding academic partner of LABMaiTE alongside BioThera Roland Mertelsmann Foundation and University Hospital Freiburg. Contributed to the visionary collaborative project that originated LABMaiTE.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Founding partner alongside BioThera Roland Mertelsmann Foundation and University of Freiburg. Ensures LABMaiTE's commitment to excellence in medical and biological research applications.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner organization supporting LABMaiTE's ecosystem and innovation initiatives.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Accelerator program partner supporting LABMaiTE's growth and development as a startup in Baden-Württemberg.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

TetraScience is a large SaaS platform that industrializes scientific data and applies AI to lab and process data across biopharma. Comparable as an adjacent enterprise AI/data platform for life science R&D, overlapping with LABMaiTE's analytics and workflow-orchestration layer.

TypeBroad incumbent
Description

Sartorius is a major bioprocess equipment and automation supplier serving cell therapy, vaccine, and biologics manufacturers. Comparable as the dominant incumbent in the bioprocess automation space where LABMaiTE's AMLAMaiTE operates, including overlap with CAR T-cell manufacturing customers.

3Culture Biosciences
TypeDirect peer
Description

Culture Biosciences offers cloud-based bioprocess development with ML-driven analysis for fermentation and cell culture optimization. Highly comparable to LABMaiTE's AMLAMaiTE system in applying probabilistic/ML models to bioprocess media optimization and scale-up.

TypeDirect peer
Description

Synthace builds a cloud biology platform that automates experimental design, execution, and data analysis for life science R&D. Directly comparable to LABMaiTE's mission of AI-driven workflow automation across cancer research and bioprocess experiments.

TypeEmerging player
Description

Insitro applies machine learning to biological data and combines high-throughput experimental biology with computational models. Comparable in using AI to accelerate biology and drug-discovery workflows, with overlap in cell imaging and bioprocess optimization themes.

TypeEmerging player
Description

Bota Biosciences applies ML-driven bioprocess tools to protein engineering and biomanufacturing optimization. Comparable as a peer emerging player building AI for bioprocess and fermentation, overlapping with LABMaiTE's AMLAMaiTE commercialization and precision fermentation customer base.

TypeEmerging player
Description

Recursion uses high-content imaging combined with ML models to characterize cellular phenotypes for drug discovery. Directly comparable in computer vision-driven cell image analysis at scale, overlapping with LABMaiTE's AI image analysis and neurodegenerative disease research use cases.

TypeBroad incumbent
Description

Yokogawa provides process automation, control systems, and bioreactor solutions for biopharma and industrial fermentation. Comparable as an incumbent in bioprocess process control where LABMaiTE's optimization and automation solutions are targeted.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LABMaiTE

Biotechnology AI Softwarelabmaite.com

LABMaiTE GmbH is a Freiburg-based AI company that builds computer-vision image analysis for cancer research and probabilistic-model bioprocess optimization (AMLAMaiTE) for biomanufacturing and precision fermentation clients.

What LABMaiTE does

LABMaiTE GmbH is a privately held German AI company founded in 2021 and headquartered in Freiburg (Türkheimerstraße 4a, HRB 725466) that builds AI and automation software for two adjacent life-science verticals: cancer research and bioprocess technology. The company was spun out of a collaboration between BioThera Roland Mertelsmann Foundation, the University of Freiburg, and the University Hospital Freiburg, and operates with a 1-10 person team of biologists, bioprocess engineers and machine learning researchers.

The company's product surface is organized around two integrated technology stacks. The first is a computer-vision-based image analysis platform that extracts cell count, viability, confluency, tracking, and membrane roughness features from label-free microscopic images and is positioned for cancer research and neurodegenerative-disease drug screening. The second is the AMLAMaiTE bioprocess optimization system, which combines advanced probabilistic models with a fully automated microbioreactor to determine optimal culture conditions and has been shown to increase biomass output by up to 30% versus traditional Design of Experiments approaches. Both stacks are protected by granted patents and are being extended into CAR T-cell production optimization through the BMBF-funded iCARus project with Hochschule Kempten.

LABMaiTE monetizes through custom AI solutions and managed bioprocess services sold via a sales-led, enterprise-targeted go-to-market motion that relies on direct engagement, 'Request a Demo' CTAs, and presence at major industry events such as ACHEMA 2024, MEDICA 2023, and the BioProScale Symposium 2024. To date, the only disclosed funding is approximately EUR 480,000 in non-dilutive BMBF grant money spread over three years for the iCARus project; no equity financing rounds, named end customers, or revenue figures have been disclosed.

LABMaiTE firmographics

Firmographics
Name
LABMaiTE
Legal name
Labmaite GmbH
Website
https://labmaite.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
LABMaiTE GmbH is a Freiburg-based AI company that builds computer-vision image analysis for cancer research and probabilistic-model bioprocess optimization (AMLAMaiTE) for biomanufacturing and precision fermentation clients.
Ownership category
akta.pro rank

LABMaiTE industry classification

Industry
Product category
Biotechnology AI Software
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Computer Systems Design and Related Services (54151)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGAJAG
Lab Automation, Instrument Control & Workflow Orchestration Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAMAK
Lab Analytics, Utilization Management & Operational Intelligence
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAAAIAE
AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • AI image analysis
  • Bioprocess optimization
  • Cell characterization software
  • Media optimization
  • Custom research automation

Where LABMaiTE is headquartered

Location

Headquarters

HQ city
Freiburg Im Breisgau
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

LABMaiTE business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. Custom AI Solutions and Services: LABMaiTE offers customized data analysis, data insights and smart experimental design services. They process client experimental data to deliver optimized conditions for maximum production, operating as a seamless extension of the client's existing process.
  2. AMLAMaiTE Bioprocess System: Tailored bioprocess solutions using their proprietary AMLAMaiTE system for media optimization in biomanufacturing and precision fermentation applications.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

LABMaiTE product offering

Product offering

Core offering

LABMaiTE develops AI-powered software and automation solutions for cancer research and bioprocess technology. Its products include the AMLAMaiTE system for media optimization using probabilistic models (demonstrating up to 30% biomass increase over DoE methods) and computer-vision-based AI image analysis for cell characterization. The company also delivers tailored automation and custom AI analytics services as a seamless extension of client laboratory workflows.

Product overview

LABMaiTE offers a unified AI and automation solutions platform comprising two main product areas: (1) AI Image Analysis and Cell Characterization modules for cancer research, providing computer vision-based analysis of microscopic images with cell count, viability, confluency, and tracking capabilities, and (2) the AMLAMaiTE system for bioprocess media optimization using advanced Probabilistic Models that outperform traditional DoE methods. The company also provides customized automation solutions as add-on modules. All products share core AI/ML technology for processing optical data and images, with the AMLAMaiTE system leveraging the same ML foundation for growth optimization. LABMaiTE's patented technology is fully-automated and AI-based, designed to save time and money across the research process.

Differentiator

Problem solved

Functional benefit

Brands

  • AMLAMaiTE: AI-powered bioprocess media optimization system using advanced Probabilistic Models to rapidly determine optimal culture conditions, outperforming traditional Design of Experiments (DoE) methods. The system achieves up to 30% increase in biomass output compared to industry standards.

Products and services

  • AI Image Analysis Computer vision software that analyzes microscopic images to extract hidden insights beyond basic features for cancer research and biology laboratories. Capabilities include cell count, cell viability, cell confluency, cell tracking, membrane roughness, and custom analyses; the AI model distinguishes active and inactive cells, matching human researchers and detecting cells that traditional methods miss. Designed for research institutions working on drug screening and neurodegenerative disease research.
  • AMLAMaiTE Bioprocess Optimization System State-of-the-art bioprocess media optimization system using advanced Probabilistic Models to rapidly determine optimal culture conditions. Outperforms traditional Design of Experiments (DoE) methods and achieves up to 30% increase in biomass output while reducing time and cost. Includes fully automated microbioreactor capabilities with real-time monitoring for biomanufacturing and precision fermentation customers.
  • Cell Characterization AI-powered cell analysis technology that accurately distinguishes active and inactive cells, matching human researchers and detecting cells that traditional methods miss. Designed to enhance drug screening for neurodegenerative diseases including Alzheimer's, multiple sclerosis, and Parkinson's for cancer research and biology laboratories.
  • Customized AI Data Analysis and Smart Experimental Design Services Professional services offering in which LABMaiTE processes client experimental data, delivers data insights and designs smart experiments to optimize culture conditions for maximum production. Operates as a managed/extension service for biomanufacturing clients using the AMLAMaiTE platform and underlying probabilistic models.

Quantifiable outcome

  • Up to 30% increase in biomass output compared to industry standards (DoE) in bacteria growth optimization with 8 media components
  • +2 more outcomes

Companies that use LABMaiTE

Customer profile

Segments3 records

Ideal customer profiles2 records

LABMaiTE technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

LABMaiTE partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Hochschule Kempten (Institut für Produktion und Informatik)coreStrategic or Co-development Partner · 1 March 2024LABMaiTE teams up with Prof. Frieder Heieck for BMBF-funded iCARus project focused on CAR T-cell production optimization. Project funded through KMU-Innovativ program with approximately €480,000 over 3 years.
  • Hochschule München (University of Applied Sciences)coreStrategic or Co-development Partner · 1 December 2023Collaborated on the AMLAMO project which wrapped up at end of 2023. Dr. Ing. Frédéric Lapierre showcased breakthrough results at BioProScale Symposium 2024. Prof. Dr. Robert Huber from Hochschule München serves on the advisory board.
  • BioThera Roland Mertelsmann FoundationcoreStrategic or Co-development PartnerFounding partner of LABMaiTE alongside University of Freiburg and University Hospital Freiburg. Ensures commitment to excellence and guides the company to real problems to solve.
  • University of FreiburgcoreStrategic or Co-development PartnerFounding academic partner of LABMaiTE alongside BioThera Roland Mertelsmann Foundation and University Hospital Freiburg. Contributed to the visionary collaborative project that originated LABMaiTE.
  • University Hospital FreiburgcoreStrategic or Co-development PartnerFounding partner alongside BioThera Roland Mertelsmann Foundation and University of Freiburg. Ensures LABMaiTE's commitment to excellence in medical and biological research applications.
  • BadenCampusminorStrategic or Co-development PartnerPartner organization supporting LABMaiTE's ecosystem and innovation initiatives.
  • Start-Up-BW-AcceleratorminorStrategic or Co-development PartnerAccelerator program partner supporting LABMaiTE's growth and development as a startup in Baden-Württemberg.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

LABMaiTE competitors and assessment

Company assessment

Broad incumbents

  • TetraScience: TetraScience is a large SaaS platform that industrializes scientific data and applies AI to lab and process data across biopharma. Comparable as an adjacent enterprise AI/data platform for life science R&D, overlapping with LABMaiTE's analytics and workflow-orchestration layer.
  • Sartorius AG: Sartorius is a major bioprocess equipment and automation supplier serving cell therapy, vaccine, and biologics manufacturers. Comparable as the dominant incumbent in the bioprocess automation space where LABMaiTE's AMLAMaiTE operates, including overlap with CAR T-cell manufacturing customers.
  • Yokogawa Electric (Bio): Yokogawa provides process automation, control systems, and bioreactor solutions for biopharma and industrial fermentation. Comparable as an incumbent in bioprocess process control where LABMaiTE's optimization and automation solutions are targeted.

Direct peers

  • Culture Biosciences: Culture Biosciences offers cloud-based bioprocess development with ML-driven analysis for fermentation and cell culture optimization. Highly comparable to LABMaiTE's AMLAMaiTE system in applying probabilistic/ML models to bioprocess media optimization and scale-up.
  • Synthace: Synthace builds a cloud biology platform that automates experimental design, execution, and data analysis for life science R&D. Directly comparable to LABMaiTE's mission of AI-driven workflow automation across cancer research and bioprocess experiments.

Emerging players

  • Insitro: Insitro applies machine learning to biological data and combines high-throughput experimental biology with computational models. Comparable in using AI to accelerate biology and drug-discovery workflows, with overlap in cell imaging and bioprocess optimization themes.
  • Bota Biosciences: Bota Biosciences applies ML-driven bioprocess tools to protein engineering and biomanufacturing optimization. Comparable as a peer emerging player building AI for bioprocess and fermentation, overlapping with LABMaiTE's AMLAMaiTE commercialization and precision fermentation customer base.
  • Recursion Pharmaceuticals: Recursion uses high-content imaging combined with ML models to characterize cellular phenotypes for drug discovery. Directly comparable in computer vision-driven cell image analysis at scale, overlapping with LABMaiTE's AI image analysis and neurodegenerative disease research use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

LABMaiTE social profiles

Digital presence

LABMaiTE financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LABMaiTE leadership team

Management profile

Number of profiles

Profiles8 records

LABMaiTE funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LABMaiTE M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LABMaiTE

What does LABMaiTE do?

LABMaiTE develops AI-powered software and automation solutions for cancer research and bioprocess technology. Its products include the AMLAMaiTE system for media optimization using probabilistic models (demonstrating up to 30% biomass increase over DoE methods) and computer-vision-based AI image analysis for cell characterization. The company also delivers tailored automation and custom AI analytics services as a seamless extension of client laboratory workflows.

Is LABMaiTE a public or private company?

LABMaiTE is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was LABMaiTE founded?

LABMaiTE was founded in 2021. It employs 11 to 50 people.

Where is LABMaiTE based?

LABMaiTE is headquartered in Freiburg Im Breisgau, Germany, in the Europe region.

How does LABMaiTE make money?

Two revenue lines are on record. Custom AI Solutions and Services are the primary driver. The others are AMLAMaiTE Bioprocess System.

Who are LABMaiTE's main competitors?

Broad incumbents on record are TetraScience, Sartorius AG and Yokogawa Electric (Bio). Direct peers are Culture Biosciences and Synthace. Emerging players are Insitro, Bota Biosciences and Recursion Pharmaceuticals.

Does LABMaiTE have an API?

No public API is recorded for LABMaiTE.

What industry is LABMaiTE in?

LABMaiTE's product category is Biotechnology AI Software. Its primary akta.pro industry code is HLAGAJAG, Lab Automation, Instrument Control & Workflow Orchestration Software, with a secondary code of HLACAMAK, Lab Analytics, Utilization Management & Operational Intelligence. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales